LUMOBRY 0.25 mg/ml, eye drop solution bottle, 7.5 ml
Active ingredients: Brimonidine, Brimonidine tartrate
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 7.5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LUMOBRY 0,25 mg/mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) multidose(s) polyéthylène basse densité (PEBD) avec compte-gouttes (incorporé) PEBDL : polyéthylène à basse densité linéaire de 7,5 ml avec fermeture de sécurité enfant
- Marketing authorisation holder
- LABORATOIRE CHAUVIN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Jan 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66375524CIP73026044CIP133400930260449Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRIMONIDINEcollyre | — | FT |
| TARTRATE DE BRIMONIDINEcollyre | 0,25 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.